Theranos Inc. pledged to stay out of the blood-testing business for at least two years in exchange for reduced penalties from federal health authorities, the company said, in an agreement that resolves a year-long regulatory impasse.
http://on.wsj.com/2oGdh2U
No comments:
Post a Comment